Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation

Journal of Neuroimmunology

Volumn 135, Issue 1-2, 2003, Pages 154-160

  Pashenkov, Mikhail ^a   Söderström, Mats ^b   Link, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CCL19; CCL21; Cerebrospinal fluid; Multiple sclerosis; Optic neuritis

Indexed keywords

CHEMOKINE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL COUNT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHRONIC INFLAMMATION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LYMPHOID ORGAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037308663     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00441-1     Document Type: Article

References (46)

1. Bajetto A., Bonavia R., Barbero S., Piccioli P., Costa A., Florio T., Schettini G. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73:1999;2348-2357.
2. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
3. Carson M.J., Reilly C.R., Sutcliffe J.G., Lo D. Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am. J. Pathol. 154:1999;481-494.
4. Chen S.C., Vassileva G., Kinsley D., Holzmann S., Manfra D., Wiekowski M.T., Romani N., Lira S.A. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:2002;1001-1008.
5. Chen S.C., Leach M.W., Chen Y., Cai X.Y., Sullivan L., Wiekowski M., Dovey-Hartman B.J., Zlotnik A., Lira S.A. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J. Immunol. 168:2002;1009-1017.
6. Cherwinski H.M., Schumacher J.H., Brown K.D., Mosmann T.R. Two types of mouse helper T cell clone: III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1987;1229-1244.
7. Colombo M., Dono M., Gazzola P., Roncella S., Valetto A., Chiorazzi N., Mancardi G.L., Ferrarini M. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J. Immunol. 164:2000;2782-2789.
8. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:1998;373-386.
9. Fischer H.G., Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166:2001;2717-2726.
10. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:1999;451-460.
11. Harling-Berg C.J., Park J.T., Knopf P.M. Role of cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J. Neuroimmunol. 101:1999;111-127.
12. Hjelmstrom P., Fjell J., Nakagawa T., Sacca R., Cuff C.A., Ruddle N.H. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156:2000;1133-1138.
13. Iguchi T., Ziff M. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J. Clin. Invest. 77:1986;355-361.
14. Kabel P.J., Voorbij H.A., de Haan-Meulman M., Pals S.T., Drexhage H.A. High endothelial venules present in lymphoid cell accumulations in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development. J. Clin. Endocrinol. Metab. 68:1989;744-751.
15. Kim C.H., Pelus L.M., White J.R., Applebaum E., Johanson K., Broxmeyer H.E. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J. Immunol. 160:1998;2418-2424.
16. Kostulas V.K., Link H. Agarose isoelectric focusing of unconcentrated CSF and radioimmunofixation for detection of oligoclonal bands in patients with multiple sclerosis and other neurological diseases. J. Neurol. Sci. 54:1982;117-127.
17. Kratz A., Campos-Neto A., Hanson M.S., Ruddle N.H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183:1996;1461-1472.
18. Kriehuber E., Breiteneder-Geleff S., Groeger M., Soleiman A., Schoppmann S.F., Stingl G., Kerjaschki D., Maurer D. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194:2001;797-808.
19. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
20. Lassmann H., Bruck W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7:2001;121-151.
21. Lin C.L., Suri R.M., Rahdon R.A., Austyn J.M., Roake J.A. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 28:1998;4114-4122.
22. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders: III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 37:1977;397-401.
23. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188:1998;1493-1501.
24. Luther S.A., Tang H.L., Hyman P.L., Farr A.G., Cyster J.G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12694-12699.
25. Matusevicius D., Navikas V., Soderstrom M., Xiao B.G., Haglund M., Fredrikson S., Link H. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. J. Neuroimmunol. 66:1996;115-123.
26. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50:2001;121-127.
27. Nagasawa T., Nakajima T., Tachibana K., Iizasa H., Bleul C.C., Yoshie O., Matsushima K., Yoshida N., Springer T.A., Kishimoto T. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14726-14729.
28. Nagasawa T., Tachibana K., Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin. Immunol. 10:1998;179-185.
29. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., Cyster J.G. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:1999;403-412.
30. Page G., Lebecque S., Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J. Immunol. 168:2002;5333-5341.
31. Pashenkov M., Huang Y.M., Kostulas V., Haglund M., Soderstrom M., Link H. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain. 124:2001;480-492.
32. Pashenkov M., Teleshova N., Kouwenhoven M., Smirnova T., Jin Y.P., Kostulas V., Huang Y.M., Pinegin B., Boiko A., Link H. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J. Neuroimmunol. 122:2002;106-116.
33. Penna G., Sozzani S., Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167:2001;1862-1866.
34. Perkin G.D., Rose F.C. Optic Neuritis and its Differential Diagnosis. 1979;Oxford Univ. Press, Oxford.
35. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
36. Prineas J.W. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science. 203:1979;1123-1125.
37. Raine C.S., Lee S.C., Scheinberg L.C., Duijvestin A.M., Cross A.H. Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis. Clin. Immunol. Immunopathol. 57:1990;173-187.
38. Sallusto F., Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming and chronic inflammation. J. Exp. Med. 189:1999;611-614.
39. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today. 19:1998;568-574.
40. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., Forster R., Burgstahler R., Lipp M., Lanzavecchia A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1999;1617-1625.
41. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:2000;593-620.
42. Serafini B., Columba-Cabezas S., Di Rosa F., Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157:2000;1991-2002.
43. Serafini B., Magliozzi R., Columba-Cabezas S., Ambrosini E., Aloisi F. Recruitment of dendritic cells and occurrence of lymphoid-like features in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol. 118:2001;5.
44. Soderstrom M., Jin Y.P., Hillert J., Link H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology. 50:1998;708-714.
45. Suen W.E., Bergman C.M., Hjelmstrom P., Ruddle N.H. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1997;1233-1240.
46. Suter T., Malipiero U., Otten L., Ludewig B., Muelethaler-Mottet A., Mach B., Reith W., Fontana A. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Eur. J. Immunol. 30:2000;794-802.